Literature DB >> 36195683

Effects of short-term hypercaloric nutrition on orthostatic tolerance in healthy individuals: a randomized controlled crossover study.

Riccardo De Gioannis1,2, Ann C Ewald1, Darius A Gerlach1, Karsten Heusser1, Fabian Hoffmann1,2, Petra Frings-Meuthen1, Martina Heer3, Jens Tank1, Jens Jordan4,5.   

Abstract

Reduced-caloric intake lowers blood pressure through sympathetic inhibition, and worsens orthostatic tolerance within days. Conversely, hypercaloric nutrition augments sympathetic activity and blood pressure. Because dietary interventions could be applied in patients with syncope, we tested the hypothesis that short-term hypercaloric dieting improves orthostatic tolerance. In a randomized crossover trial, 20 healthy individuals (7 women, 26.7 ± 8 years, 22.6 ± 2 kg/m2) followed a 4-day hypercaloric (25% increase of energy intake by fat) or normocaloric nutritional plan, with a washout period of at least 23 days between interventions. We then performed head-up tilt table testing with incremental lower body negative pressure while recording beat-by-beat blood pressure and heart rate. The primary endpoint was orthostatic tolerance defined as time to presyncope. Time to presyncope during combined head-up tilt and lower body negative pressure did not differ between hypercaloric and normocaloric dieting (median 23.19 versus 23.04 min, ratio of median 1.01, 95% CI of ratio 0.5-1.9). Heart rate, blood pressure, heart rate variability, and blood pressure variability in the supine position and during orthostatic testing did not differ between interventions. We conclude that 4 days of moderate hypercaloric nutrition does not significantly improve orthostatic tolerance in healthy individuals. Nevertheless, given the important interaction between energy balance and cardiovascular autonomic control in the brain, caloric intake deserves more attention as a potential contributor and treatment target for orthostatic intolerance.
© 2022. The Author(s).

Entities:  

Keywords:  Diet; Hypercaloric; Metabolism; Neurally mediated syncope; Sympathetic nervous system

Year:  2022        PMID: 36195683     DOI: 10.1007/s10286-022-00900-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   5.625


  28 in total

1.  2018 ESC Guidelines for the diagnosis and management of syncope.

Authors:  Michele Brignole; Angel Moya; Frederik J de Lange; Jean-Claude Deharo; Perry M Elliott; Alessandra Fanciulli; Artur Fedorowski; Raffaello Furlan; Rose Anne Kenny; Alfonso Martín; Vincent Probst; Matthew J Reed; Ciara P Rice; Richard Sutton; Andrea Ungar; J Gert van Dijk
Journal:  Eur Heart J       Date:  2018-06-01       Impact factor: 29.983

2.  Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.

Authors:  Stuart J Connolly; Robert Sheldon; Kevin E Thorpe; Robin S Roberts; Kenneth A Ellenbogen; Bruce L Wilkoff; Carlos Morillo; Michael Gent
Journal:  JAMA       Date:  2003-05-07       Impact factor: 56.272

3.  Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men.

Authors:  Sebastiaan Hammer; Rutger W van der Meer; Hildo J Lamb; Michael Schär; Albert de Roos; Jan W A Smit; Johannes A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2007-11-20       Impact factor: 5.958

4.  New-onset orthostatic intolerance following bariatric surgery.

Authors:  Sreedhar R Billakanty; Mark D Kligman; Yousuf M Kanjwal; Daniel J Kosinski; George T Maly; Beverly Karabin; Blair P Grubb
Journal:  Pacing Clin Electrophysiol       Date:  2008-07       Impact factor: 1.976

5.  Sympathetic activation in obese normotensive subjects.

Authors:  G Grassi; G Seravalle; B M Cattaneo; G B Bolla; A Lanfranchi; M Colombo; C Giannattasio; A Brunani; F Cavagnini; G Mancia
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

6.  Heart rate and blood pressure variability and baroreflex sensitivity in patients with anorexia nervosa.

Authors:  Tetsuro Ishizawa; Kazuhiro Yoshiuchi; Yoshiyuki Takimoto; Yoshiharu Yamamoto; Akira Akabayashi
Journal:  Psychosom Med       Date:  2008-07       Impact factor: 4.312

7.  Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.

Authors:  Benjamin Barzel; Kyungjoon Lim; Pamela J Davern; Sandra L Burke; James A Armitage; Geoffrey A Head
Journal:  J Hypertens       Date:  2016-03       Impact factor: 4.844

8.  Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia.

Authors:  Benjamin Barzel; Jacquelyn M Weir; Peter J Meikle; Sandra L Burke; James A Armitage; Geoffrey A Head
Journal:  Front Physiol       Date:  2014-12-02       Impact factor: 4.566

9.  Caloric restriction decreases orthostatic tolerance independently from 6° head-down bedrest.

Authors:  John P Florian; Friedhelm J Baisch; Martina Heer; James A Pawelczyk
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  Cardiac adaptations to 60 day head-down-tilt bed rest deconditioning. Findings from the AGBRESA study.

Authors:  Fabian Hoffmann; Jérémy Rabineau; Dennis Mehrkens; Darius A Gerlach; Stefan Moestl; Bernd W Johannes; Enrico G Caiani; Pierre Francois Migeotte; Jens Jordan; Jens Tank
Journal:  ESC Heart Fail       Date:  2020-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.